학술논문

Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial
Document Type
Article
Author
Funke, AndreasKettemann, DagmarMeyer, RobertMeyer, ThomasGrehl, TorstenGruhn, KaiSchwenkreis, PeterStude, PhilippHeneka, Michael TKurzwelly, DeliaHermann, AndreasStorch, AlexanderRichter, NicoleFrank, TobiasGöricke, BettinaHein, KatharinaEmmer, AlexanderHanisch, FrankHanke, DagmarKraya, TorstenPosa, AndreasRomanakova, MartinaSchilling, SusanneAbdulla, SusanneBöselt, SebastianJanssen, ClaasLange, ImkenKobeleva, XeniaKörner, SonjaKollewe, KatjaOsmanovic, AlmaPetri, SusanneScharn, NicoleRath, Klaus JDahms, ChristianeGrosskreutz, JulianGunkel, AnneHeiling, BiankaRinger, ThomasSmesny, UtaBaumeister, SarahBerthele, AchimBublitz, SarahWinkler, Andrea SAkova-Öztürk, EsraBoentert, MatthiasStubbe-Dräger, BiancaRahmann, AlexandraYoung, CharlotteYoung, PeterBaldaranov, DobriBogdahn, UlrichWollebæk Johannesen, SiwKhomenko, AndreiSchulte-Mattler, WilhelmStadler, ChristinaHusung, SusannePrudlo, JohannesTesar, SimoneDargah-Zaden, NigarLast, ChristinaLanger, EvaLudolph, Albert CWeishaupt, Jochen HWeiland, UlrikeLauenstein, Ann-SophieLensch, EckardMc Farlane, CarolynFischer-Brasse, HeikeOrbán, KlaraSchrank, BertoldSchürger, SonjaKlebe, StephanKraft, PeterMusacchio, ThomasSeiler, CarolaZeller, DanielSchuster, JoachimDorst, JohannesDupuis, LucDreyhaupt, JensKassubek, JanSchrank, Berthold
Source
In The Lancet Neurology August 2018 17(8):681-688
Subject
Primary Research
Articles
Language
ISSN
1474-4422